Sam Chun Dang Pharm Co Ltd KRX:000250:
EUROPEAN MEDICINES AGENCY APPROVES PHASE I CLINICAL STUDY PLAN ON ORAL INSULIN IN GERMANY
Sam Chun Dang Pharm Co European Medicines Agency Approves Phase I Clinical Study Plan On Oral Insulin In Germany
Earlier from Sam Chun Dang Pharm
- Sam Chun Dang Pharm Co To Buy 9.9 Billion Won Worth Of Shares In Optus Pharmaceutical
- Citibank Korea geared for water purification at Gyeongin Ara Waterway
- Citibank Korea Inc. launches the new Shinsegae Citi Rewards Card